West Pharmaceutical Services | WST - Current Liabilities


West Pharmaceutical Services reported $640.5M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Align Technology USD 1.91B 2.74M Jun/2026
Baxter International USD 3.59B 102M Jun/2026
Becton, Dickinson and Co. USD 9.4B 897M Jun/2026
Cerus USD 100.8M 12.37M Dec/2025
Charles River Laboratories USD 1.13B 41.04M Jun/2026
Cooper Companies USD 1.8B 209M Mar/2026
Dentsply International USD 1.18B 22M Jun/2026
Haemonetics USD 263.24M 19.36M Jun/2026
ICU Medical USD 498.36M 19.54M Jun/2026
Insulet USD 744.2M 56.7M Jun/2026
Integra LifeSciences USD 330.88M 15.96M Jun/2026
IQVIA Holdings USD 8.82B 486M Jun/2026
J&J USD 54.9B 2.82B Jun/2026
Medtronic USD 9.5B 440M Dec/2025
Merit Medical Systems USD 264.93M 48.06M Jun/2026
Neogen USD 158.2M 7.6M Mar/2026
OraSure Technologies USD 25.12M 18.96M Jun/2026
Quidel USD 993.4M 31M Jun/2026
Repligen USD 132.66M 6.45M Jun/2026
Rockwell Medical USD 10.95M 259K Jun/2025
Solventum Corp USD 3.66B 317M Jun/2026
STAAR Surgical USD 73.39M 12.4M Jun/2026
Terumo JPY 413.28B 127.46B Jun/2026
Utah Medical Products USD 3.5M 907K Mar/2026
West Pharmaceutical Services USD 640.5M 33.5M Jun/2026